Advertisement
Screener

PTC Therapeutics, Inc. (PTCT) Increase (Decrease) in Prepaid Expense and Other Assets

PTC Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$9.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30

  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$8.36M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.18M, a 107.18% decline year-over-year.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $22.94M, a 149.53% increase year-over-year.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.68M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $36.82M.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$98.76M, a 319.51% decline from fiscal 2023.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $44.99M, a 12.84% decline from fiscal 2022.
  • PTC Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $51.62M, a 237.17% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$8.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$9.54M
10-Q · filed 2026-07-30
$13.40M
derived: sum of 3 quarters · filed 2026-07-30
$15.08M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$1.18M
10-Q · filed 2026-05-07
$21.76M
derived: sum of 2 quarters · filed 2026-05-07
$23.44M
derived: sum of 3 quarters · filed 2026-05-07
$19.21M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$22.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$24.62M
derived: sum of 2 quarters · filed 2026-02-19
$20.39M
derived: sum of 3 quarters · filed 2026-07-30
$36.82M
10-K · filed 2026-02-19
2025-09-30$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$2.55M
derived: sum of 2 quarters · filed 2026-07-30
$13.88M
10-Q · filed 2025-11-04
$23.07M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$4.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$12.20M
10-Q · filed 2026-07-30
$21.39M
derived: sum of 3 quarters · filed 2026-07-30
$13.22M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$16.43M
10-Q · filed 2026-05-07
$25.62M
derived: sum of 2 quarters · filed 2026-05-07
$17.46M
derived: sum of 3 quarters · filed 2026-05-07
$11.57M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$9.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$1.03M
derived: sum of 2 quarters · filed 2026-02-19
-$4.86M
derived: sum of 3 quarters · filed 2026-02-19
-$98.76M
10-K · filed 2026-02-19
2024-09-30-$8.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$14.05M
derived: sum of 2 quarters · filed 2025-11-04
-$107.96M
10-Q · filed 2025-11-04
-$3.50M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$5.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$99.79M
10-Q · filed 2025-08-07
$4.67M
derived: sum of 3 quarters · filed 2026-02-19
$9.15M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$93.90M
10-Q · filed 2025-05-06
$10.55M
derived: sum of 2 quarters · filed 2026-02-19
$15.04M
derived: sum of 3 quarters · filed 2026-02-19
$8.70M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$104.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$108.94M
derived: sum of 2 quarters · filed 2026-02-19
$102.60M
derived: sum of 3 quarters · filed 2026-02-19
$44.99M
10-K · filed 2026-02-19
2023-09-30$4.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$1.86M
derived: sum of 2 quarters · filed 2024-11-07
-$59.47M
10-Q · filed 2024-11-07
-$43.46M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$6.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$63.95M
10-Q · filed 2024-08-08
-$47.95M
derived: sum of 3 quarters · filed 2025-02-27
$4.10M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$57.61M
10-Q · filed 2024-04-25
-$41.60M
derived: sum of 2 quarters · filed 2025-02-27
$10.44M
derived: sum of 3 quarters · filed 2025-02-27
$19.13M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$16.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$68.05M
derived: sum of 2 quarters · filed 2025-02-27
$76.74M
derived: sum of 3 quarters · filed 2025-02-27
$51.62M
10-K · filed 2025-02-27
2022-09-30$52.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$60.73M
derived: sum of 2 quarters · filed 2023-10-26
$35.62M
10-Q · filed 2023-10-26
$59.09M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$8.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$16.43M
10-Q · filed 2023-08-03
$7.04M
derived: sum of 3 quarters · filed 2024-02-29
$14.53M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$25.12M
10-Q · filed 2023-04-27
-$1.65M
derived: sum of 2 quarters · filed 2024-02-29
$5.84M
derived: sum of 3 quarters · filed 2024-02-29
$5.80M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$23.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$30.96M
derived: sum of 2 quarters · filed 2024-02-29
$30.91M
derived: sum of 3 quarters · filed 2024-02-29
$15.31M
10-K · filed 2024-02-29
2021-09-30$7.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$7.44M
derived: sum of 2 quarters · filed 2022-10-27
-$8.16M
10-Q · filed 2022-10-27
-$4.83M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30-$44.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$15.65M
10-Q · filed 2022-08-04
-$12.32M
derived: sum of 3 quarters · filed 2023-02-21
-$19.60M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31-$15.61M
10-Q · filed 2022-05-03
-$12.27M
derived: sum of 2 quarters · filed 2023-02-21
-$19.55M
derived: sum of 3 quarters · filed 2023-02-21
-$9.66M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
-$3.95M
derived: sum of 2 quarters · filed 2023-02-21
$5.95M
derived: sum of 3 quarters · filed 2023-02-21
$12.62M
10-K · filed 2023-02-21
2020-09-30-$7.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$2.61M
derived: sum of 2 quarters · filed 2021-10-28
$9.29M
10-Q · filed 2021-10-28
$6.35M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30$9.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
$16.57M
10-Q · filed 2021-07-29
$13.63M
derived: sum of 3 quarters · filed 2022-02-22
$18.15M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31$6.67M
10-Q · filed 2021-05-04
$3.74M
derived: sum of 2 quarters · filed 2022-02-22
$8.26M
derived: sum of 3 quarters · filed 2022-02-22
$15.32M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31-$2.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$1.58M
derived: sum of 2 quarters · filed 2022-02-22
$8.64M
derived: sum of 3 quarters · filed 2022-02-22
$8.84M
10-K · filed 2022-02-22
2019-09-30$4.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$11.58M
derived: sum of 2 quarters · filed 2020-10-29
$11.77M
10-Q · filed 2020-10-29
$12.08M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$7.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$7.25M
10-Q · filed 2020-08-05
$7.56M
derived: sum of 3 quarters · filed 2021-02-25
$9.11M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$191.00K
10-Q · filed 2020-04-30
$499.00K
derived: sum of 2 quarters · filed 2021-02-25
$2.05M
derived: sum of 3 quarters · filed 2021-02-25
$2.76M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$308.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.86M
derived: sum of 2 quarters · filed 2021-02-25
$2.57M
derived: sum of 3 quarters · filed 2021-02-25
$1.61M
10-K · filed 2021-02-25
2018-09-30$1.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$2.26M
derived: sum of 2 quarters · filed 2019-10-30
$1.30M
10-Q · filed 2019-10-30
$2.52M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$704.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$254.00K
10-Q · filed 2019-08-06
$960.00K
derived: sum of 3 quarters · filed 2020-03-02
$1.11M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$958.00K
10-Q · filed 2019-05-02
$256.00K
derived: sum of 2 quarters · filed 2020-03-02
$410.00K
derived: sum of 3 quarters · filed 2020-03-02
$919.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$1.37M
derived: sum of 2 quarters · filed 2020-03-02
$1.88M
derived: sum of 3 quarters · filed 2020-03-02
$1.78M
10-K · filed 2020-03-02
2017-09-30$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
$663.00K
derived: sum of 2 quarters · filed 2018-11-05
$570.00K
10-Q · filed 2018-11-05
$494.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$509.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$416.00K
10-Q · filed 2018-08-07
$340.00K
derived: sum of 3 quarters · filed 2019-03-01
$408.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$93.00K
10-Q · filed 2018-05-09
-$169.00K
derived: sum of 2 quarters · filed 2019-03-01
-$101.00K
derived: sum of 3 quarters · filed 2019-03-01
-$562.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$76.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$8.00K
derived: sum of 2 quarters · filed 2019-03-01
-$469.00K
derived: sum of 3 quarters · filed 2019-03-01
-$1.17M
10-K · filed 2019-03-01
2016-09-30$68.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$393.00K
derived: sum of 2 quarters · filed 2017-11-02
-$1.09M
10-Q · filed 2017-11-02
$264.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30-$461.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$1.16M
10-Q · filed 2017-08-09
$196.00K
derived: sum of 3 quarters · filed 2018-03-06
$588.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31-$702.00K
10-Q · filed 2017-05-08
$657.00K
derived: sum of 2 quarters · filed 2018-03-06
$1.05M
derived: sum of 3 quarters · filed 2018-03-06
-$826.00K
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$1.75M
derived: sum of 2 quarters · filed 2018-03-06
-$124.00K
derived: sum of 3 quarters · filed 2018-03-06
$2.11M
10-K · filed 2018-03-06
2015-09-30$392.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$1.48M
derived: sum of 2 quarters · filed 2016-11-03
$748.00K
10-Q · filed 2016-11-03
$1.80M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$1.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$356.00K
10-Q · filed 2016-08-04
$1.41M
derived: sum of 3 quarters · filed 2017-03-16
$1.64M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.23M
10-Q · filed 2016-05-05
$3.29M
derived: sum of 2 quarters · filed 2017-03-16
$3.52M
derived: sum of 3 quarters · filed 2017-03-16
$4.16M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$1.29M
derived: sum of 2 quarters · filed 2017-03-16
$1.93M
derived: sum of 3 quarters · filed 2017-03-16
$2.29M
10-K · filed 2017-03-16
2014-09-30$234.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$874.00K
derived: sum of 2 quarters · filed 2015-11-09
$1.23M
10-Q · filed 2015-11-09
$704.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$640.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31
$998.00K
10-Q · filed 2015-07-31
$470.00K
derived: sum of 3 quarters · filed 2016-02-29
$998.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$358.00K
10-Q · filed 2015-05-05
-$170.00K
derived: sum of 2 quarters · filed 2016-02-29
$358.00K
derived: sum of 3 quarters · filed 2016-02-29
$1.09M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$735.00K
derived: sum of 3 quarters · filed 2016-02-29
$760.00K
10-K · filed 2016-02-29
$760.50K
10-K · filed 2014-03-06
2013-09-30$528.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$1.26M
derived: sum of 2 quarters · filed 2014-11-06
$1.29M
10-Q · filed 2014-11-06
$1.29M
10-Q · filed 2013-11-14
$1.09M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$735.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$760.00K
10-Q · filed 2014-08-07
$759.83K
10-Q · filed 2013-08-13
$558.09K
derived: sum of 3 quarters · filed 2015-03-02
-$5.50M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$25.00K
10-Q · filed 2014-05-06
-$176.91K
derived: sum of 2 quarters · filed 2015-03-02
-$6.24M
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31-$201.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$6.26M
derived: sum of 2 quarters · filed 2015-03-02
-$2.45M
10-K · filed 2015-03-02
-$2.45M
10-K · filed 2014-03-06
2012-09-30-$6.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$2.25M
10-Q · filed 2013-11-14
2012-06-30$3.81M
10-Q · filed 2013-08-13
2011-12-31$1.36M
10-K · filed 2014-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Veradermics, Inc (MANE)United States$4.839B
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51